Colorado Medtech buys Creos

Article

Imaging OEM component provider Colorado Medtech has added to its medical imaging portfolio with the acquisition of Creos Technologies, an Englewood, CO-based provider of x-ray generator subsystems. Boulder, CO-based Colorado Medtech purchased Creos for

Imaging OEM component provider Colorado Medtech has added to its medical imaging portfolio with the acquisition of Creos Technologies, an Englewood, CO-based provider of x-ray generator subsystems. Boulder, CO-based Colorado Medtech purchased Creos for $2 million and plans to integrate the assets into its Imaging and Power Systems division, which designs and develops MRI components and systems for OEMs. Colorado Medtech also develops and manufactures electromechanical assemblies and software for ultrasound, CT, x-ray, and nuclear medicine systems.
In a related story, a Colorado Tech student buys Oreos.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.